AUPH - Aurinia Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AUPH is currently covered by 3 analysts with an average price target of $17.5. This is a potential upside of $0.98 (5.93%) from yesterday's end of day stock price of $16.52.

Aurinia Pharmaceuticals's activity chart (see below) currently has 118 price targets and 99 ratings on display. The stock rating distribution of AUPH is 50% BUY and 50% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 81.18% with an average time for these price targets to be met of 391.85 days.

Highest price target for AUPH is $21, Lowest price target is $15, average price target is $17.5.

Most recent stock forecast was given by DOUGLAS MIEHM from RBC on 07-Aug-2026. First documented stock forecast 30-Jun-2016.

Best performing analysts who are covering AUPH - Aurinia Pharmaceuticals:

Alethia Young Elemer Piros Ed Arce Maury Raycroft Justin Kim Joseph Schwartz Douglas Miehm

Currently out of the existing stock ratings of AUPH, 2 are a BUY (50%), 2 are a HOLD (50%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 07-Aug-2026

$16

$-0.44 (-2.68%)

$15

1 months 22 days ago
(07-Aug-2026)

14/19 (73.68%)

$0.15 (0.95%)

213

Buy Since 06-Oct-2016

$16

$-0.44 (-2.68%)

$10

9 months 26 days ago
(03-Dec-2025)

9/12 (75%)

$1.09 (7.31%)

429

Hold Since 02-May-2024

$21

$4.56 (27.74%)

$6

10 months 22 days ago
(07-Nov-2025)

3/4 (75%)

$6.39 (43.74%)

398

Buy Since 30-Jul-2025

$17

$-0.23 (-1.33%)

1 years 1 months 30 days ago
(30-Jul-2025)

1/1 (100%)

$7.95 (87.85%)

327

Buy Since 15-Feb-2024

$11

$-5.44 (-33.09%)

$11

1 years 2 months 30 days ago
(30-Jun-2025)

2/2 (100%)

$2.53 (29.87%)

286

Show more analysts

Please expand the browser size to see the chart

What is AUPH (Aurinia Pharmaceuticals) average time for price targets to be met?

On average it took 392 days for the stock forecasts to be reached, with an average price target met ratio of 81.18%.

Which analyst most recently updated their price target on AUPH (Aurinia Pharmaceuticals)?

Douglas Miehm

Which analyst has the most public recommendations on AUPH (Aurinia Pharmaceuticals)?

Douglas Miehm works at RBC and has 4 price targets and 2 ratings on AUPH

Which analyst is the currently most bullish on AUPH (Aurinia Pharmaceuticals)?

Ken Cacciatore with the highest potential upside of $18.56

Which analyst is the currently most reserved on AUPH (Aurinia Pharmaceuticals)?

Olivia Brayer with the lowest potential downside of -$7.23
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?